The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical drug discovery, identifying which offer the best return on investment and opportunities to maximize drug discovery productivity. The leading players in the drug discovery market are competitively positioned and profiled, enabling potential M&A targets and opportunities for licensing deals and alliances/joint ventures to be identified. The report further assesses the impact of pharmacoeconomics on the drug discovery function to 2005 and its implications for future R&D project management and focus.
